PECAM1 and myeloid sarcoma: Endothelial PECAM-1 staining was most pronounced in initial (pre-phagocytic) MS lesions (Figure 1G), while it was less strong in the PPWM (Figure 1F), active demyelinating lesions (Figure 1H) or the NWM of controls (Figure 1E).